Kentucky is the fourth state to allow insurers to require biosimilar prescriptions before branded versions

Lia DeGroot

Kentucky passed a law allowing insurers to encourage patients to try biosimilar medicines before covering the branded equivalent to expand access to lower-cost medicines. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Kentucky is the fourth state to allow insurers to require biosimilar prescriptions before branded versions

Lia DeGroot

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Biopharma begins to contemplate an RFK Jr.-influenced FDA if Trump wins

Pfizer shares new details on obesity pipeline, hints at ‘other opportunities’

GSK buys autoimmune T cell engager for $300M upfront from Chimagen

Novartis takes $800M MorphoSys writedown mere months after closing acquisition

Novartis highlights overall M&A track record following MorphoSys impairment

Following March inspection, Novo Nordisk's semaglutide manufacturing facility cited by FDA

Ken­tucky is the fourth state to al­low in­sur­ers to re­quire biosim­i­lar pre­scrip­tions be­fore brand­ed ver­sions

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Kentucky is the fourth state to allow insurers to require biosimilar prescriptions before branded versions